Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib
JAMA Oncology | October 18, 2021 | Volume: 7 | Issue: 12 | Pages: 1772
10.1001/jamaoncol.2021.4664
| PMID 34647981